Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G0FQ
|
|||
Former ID |
DIB009667
|
|||
Drug Name |
IMA-950
|
|||
Synonyms |
Tumor-associated peptide vaccine (glioblastoma), immatics
Click to Show/Hide
|
|||
Indication | Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] | Phase 1 | [1] | |
Company |
Immatics biotechnologies
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01403285) Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.